Centivax
4 known investors
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Investors · 4
In the news
- Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readinessprnewswire.com · 2026
- Centivax Raises $37M in Fundingfinsmes.com · 2026
- Sell or Invest in Centivax Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Flu vaccine startup raises $45 million, says tech could eventually tackle COVID, HIVaxios.com · 2025
- Centivax raises $45M in funding to launch first-ever universal flu vaccine to human trials - Tech Startupstechstartups.com · 2025
- Centivax Raises Oversubscribed $45 Million Series A Led by Future Ventures to Advance Universal Flu Vaccine into Clinic and Expand Universal Immunity Portfolioprnewswire.com · 2025